Ying Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ying Zhang has a total of 236 co-authors. Here are the top co-authors by number of shared publications:
- Jason Gari Umans
Georgetown University
14 shared publications - Shelley A. Cole
Population Health Program, Texas Biomedical Research Institute, San Antonio, TX (S.A.C.).
10 shared publications Elisa T. Lee
University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
9 shared publicationsRichard B. Devereux
Weill Cornell Medical College
8 shared publications- Amanda M. Fretts
University of Washington
7 shared publications Barbara V. Howard
MedStar Health Research Institute, Hyattsville, MD, USA; Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC, USA
7 shared publications
Latest Publications
- 6 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (19) , e048758
Achievement of the American Heart Association Life's Essential 8 Goals With Death Among American Indian People: The Strong Heart Family Study
Background: The American Heart Association's Life's Essential 8 is a metric used to assess cardiovascular health (CVH) that includes 4 health behaviors and 4 health factors. We examined the association of achievement of Life's Essential 8 with death among American Indian people who participated in the SHFS (Strong Heart Family Study), a study of cardiovascular disease risk factors in 12 rural American Indian communities in the United States. Methods: A total of 2230 SHFS participants were included. A composite CVH score (0–100) was created on the basis of the achievement of Life's Essential 8 goals except sleep and categorized into low (0–49), moderate (50–69), and high (70–100) CVH. Cox proportional hazards models were used to examine the association of CVH with mortality risk (all‐cause and cardiovascular disease death). Results: There were 555 deaths over a median 19.3‐year follow‐up. The risk of death from any cause was lower among participants who achieved high CVH (hazard ratio [HR], 0.52 [95% CI, 0.38–0.70]) or moderate CVH (HR, 0.67 [95% CI, 0.56–0.78]) compared with those with low CVH. Similarly, the risk of death from cardiovascular disease was lower among participants with high CVH (HR, 0.30 [95% CI, 0.14–0.67]) or moderate CVH (HR, 0.56 [95% CI, 0.39–0.79]) compared with participants with low CVH. Conclusions: Higher achievement of Life's Essential 8 was associated with lower risk of all‐cause and cardiovascular disease death. This work highlights the importance of promoting optimal CVH to minimize risk of death in American Indian communities.
- 6 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (19) , e048758
Achievement of the American Heart Association Life's Essential 8 Goals With Death Among American Indian People: The Strong Heart Family Study
Background: The American Heart Association's Life's Essential 8 is a metric used to assess cardiovascular health (CVH) that includes 4 health behaviors and 4 health factors. We examined the association of achievement of Life's Essential 8 with death among American Indian people who participated in the SHFS (Strong Heart Family Study), a study of cardiovascular disease risk factors in 12 rural American Indian communities in the United States. Methods: A total of 2230 SHFS participants were included. A composite CVH score (0–100) was created on the basis of the achievement of Life's Essential 8 goals except sleep and categorized into low (0–49), moderate (50–69), and high (70–100) CVH. Cox proportional hazards models were used to examine the association of CVH with mortality risk (all‐cause and cardiovascular disease death). Results: There were 555 deaths over a median 19.3‐year follow‐up. The risk of death from any cause was lower among participants who achieved high CVH (hazard ratio [HR], 0.52 [95% CI, 0.38–0.70]) or moderate CVH (HR, 0.67 [95% CI, 0.56–0.78]) compared with those with low CVH. Similarly, the risk of death from cardiovascular disease was lower among participants with high CVH (HR, 0.30 [95% CI, 0.14–0.67]) or moderate CVH (HR, 0.56 [95% CI, 0.39–0.79]) compared with participants with low CVH. Conclusions: Higher achievement of Life's Essential 8 was associated with lower risk of all‐cause and cardiovascular disease death. This work highlights the importance of promoting optimal CVH to minimize risk of death in American Indian communities.
- 1 September 2026
- Published by Wolters Kluwer Health in Biopsychosocial Science and Medicine
- Vol. 88 (8) , 666-676
Associations of Depressive Symptoms With COVID-19 Hospitalization or Death: The C4R Study
Objective: To investigate the relationship between depressive symptoms and risk for COVID-19 hospitalization and death in a US general population-based sample. Methods: We studied participants enrolled in observational NIH-funded cohorts from 1971 to 2010 with ongoing follow-up through 2023. Prepandemic Centers for Epidemiologic Studies Depression (CES-D) 10-item scale scores ≥10 defined elevated depressive symptoms. Questionnaires, medical records, and death certificates classified incidents of COVID-19 as severe (hospitalized/fatal) or nonsevere from April 2020 through February 2023. Results: Of 33,565 participants, 633 (1.9%) had incident severe COVID-19 over a mean (SD) follow-up of 453 (207) days. Elevated prepandemic depressive symptoms were present in 4922 (16.3%) of participants. Elevated prepandemic depressive symptoms increased the hazard of severe COVID-19 in fully adjusted (aHR=1.27; 95% CI=1.03-1.57) models. In sex-stratified models ( p -interaction=.03), elevated depressive symptoms increased the hazard in women (aHR=1.49; 95% CI=1.17-1.90) but not in men (aHR=0.96; 95% CI=0.67-1.39). Conclusions: Prepandemic depressive symptoms were associated with increased risk of severe COVID-19 among women in a large US general population-based study of adults, and associations in men were neither confirmed nor ruled out. These results support current CDC recommendations that depression be considered an underlying medical condition associated with a higher risk for severe COVID-19 and suggest that increased clinical focus on risk mitigation for COVID-19 and other acute respiratory infections among patients with depressive symptoms is warranted.
- 1 September 2026
- Published by Wolters Kluwer Health in Biopsychosocial Science and Medicine
- Vol. 88 (8) , 666-676
Associations of Depressive Symptoms With COVID-19 Hospitalization or Death: The C4R Study
Objective: To investigate the relationship between depressive symptoms and risk for COVID-19 hospitalization and death in a US general population-based sample. Methods: We studied participants enrolled in observational NIH-funded cohorts from 1971 to 2010 with ongoing follow-up through 2023. Prepandemic Centers for Epidemiologic Studies Depression (CES-D) 10-item scale scores ≥10 defined elevated depressive symptoms. Questionnaires, medical records, and death certificates classified incidents of COVID-19 as severe (hospitalized/fatal) or nonsevere from April 2020 through February 2023. Results: Of 33,565 participants, 633 (1.9%) had incident severe COVID-19 over a mean (SD) follow-up of 453 (207) days. Elevated prepandemic depressive symptoms were present in 4922 (16.3%) of participants. Elevated prepandemic depressive symptoms increased the hazard of severe COVID-19 in fully adjusted (aHR=1.27; 95% CI=1.03-1.57) models. In sex-stratified models ( p -interaction=.03), elevated depressive symptoms increased the hazard in women (aHR=1.49; 95% CI=1.17-1.90) but not in men (aHR=0.96; 95% CI=0.67-1.39). Conclusions: Prepandemic depressive symptoms were associated with increased risk of severe COVID-19 among women in a large US general population-based study of adults, and associations in men were neither confirmed nor ruled out. These results support current CDC recommendations that depression be considered an underlying medical condition associated with a higher risk for severe COVID-19 and suggest that increased clinical focus on risk mitigation for COVID-19 and other acute respiratory infections among patients with depressive symptoms is warranted.
- Open Access
- 19 May 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (10) , e046020
Lipidomic Markers of Tobacco Use and Cessation Associated With Cardiovascular Risk Factors: A Longitudinal Study in American Indian Individuals
Background: Research is warranted to identify lipidomic markers longitudinally associated with tobacco smoking and cessation and examine their associations with cardiovascular risk metrics. Methods: Using untargeted liquid chromatography–mass spectrometry, we measured 1542 lipids among 1845 American Indian individuals at 2 visits (~5.5 years apart). Information on smoking and cessation was collected using questionnaires at both visits. Using mixed‐effects linear regression, we first identified lipids associated with current smoking between current and never smokers and past smoking between former and never smokers. Random effects were used to account for family relatedness and within‐individual correlations across visits. We then investigated whether longitudinal changes in smoking‐related lipids were associated with smoking cessation that occurred between baseline and follow‐up. We examined the longitudinal associations of a lipidomic score and each lipid with various cardiovascular risk metrics. Results: Concentrations of 126 named lipids differed between current and never smokers (false discovery rateP <0.05, cessation was linked to decreases in 8 of 50 upregulated lipids (eg, lysoglycerophospholipids) and increases in 11 of 76 downregulated lipids (eg, sphingomyelins). The lipidomic score and multiple individual lipids were associated with blood pressure, waist circumference, C‐reactive protein, fasting glucose, insulin resistance, and insulin sensitivity. Conclusions: Current smoking, but not past smoking, is associated with a broad range of lipidomic markers in American Indian individuals. Longitudinal profiling reveals suggestive evidence of lipidomic markers recovering after cessation. Once validated, these findings may elucidate key lipid pathways underlying the effects of smoking and cessation.
- 19 May 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (10) , e046020
Open AccessLipidomic Markers of Tobacco Use and Cessation Associated With Cardiovascular Risk Factors: A Longitudinal Study in American Indian Individuals
Background: Research is warranted to identify lipidomic markers longitudinally associated with tobacco smoking and cessation and examine their associations with cardiovascular risk metrics. Methods: Using untargeted liquid chromatography–mass spectrometry, we measured 1542 lipids among 1845 American Indian individuals at 2 visits (~5.5 years apart). Information on smoking and cessation was collected using questionnaires at both visits. Using mixed‐effects linear regression, we first identified lipids associated with current smoking between current and never smokers and past smoking between former and never smokers. Random effects were used to account for family relatedness and within‐individual correlations across visits. We then investigated whether longitudinal changes in smoking‐related lipids were associated with smoking cessation that occurred between baseline and follow‐up. We examined the longitudinal associations of a lipidomic score and each lipid with various cardiovascular risk metrics. Results: Concentrations of 126 named lipids differed between current and never smokers (false discovery rateP <0.05, cessation was linked to decreases in 8 of 50 upregulated lipids (eg, lysoglycerophospholipids) and increases in 11 of 76 downregulated lipids (eg, sphingomyelins). The lipidomic score and multiple individual lipids were associated with blood pressure, waist circumference, C‐reactive protein, fasting glucose, insulin resistance, and insulin sensitivity. Conclusions: Current smoking, but not past smoking, is associated with a broad range of lipidomic markers in American Indian individuals. Longitudinal profiling reveals suggestive evidence of lipidomic markers recovering after cessation. Once validated, these findings may elucidate key lipid pathways underlying the effects of smoking and cessation.
- Open Access
Bridging the Genomic Equity Gap with Context-Enhanced Risk Stratification in American Indians: the Strong Heart Study
Polygenic scores (PGS) show promise for disease risk stratification but suffer from limited portability across populations. American Indians face a disproportionate burden of cardiovascular disease yet remain significantly underrepresented in genomic research, limiting equitable access to precision medicine. Here, we evaluate whether integrating specific lifestyle and clinical context variables with PGS enhances risk prediction for cardiometabolic traits in 424,622 European from UK Biobank (UKB) and 3,157 American Indian populations from the Strong Heart Study (SHS). By comparing genetics-only models to full models incorporating context variables and gene-context interactions across blood pressure traits, coronary heart disease (CHD), and stroke, we found that the integration of context variables significantly improved prediction accuracy in both cohorts. Notably, for American Indian participants, the new model incorporating context and genetic interactions significantly improved model discrimination for CHD compared to an established clinical risk model. These findings suggest that modeling the interplay between inherited risk and modifiable factors can recover predictive power loss due to imperfect PGS transferability, offering a viable pathway toward more equitable and effective precision medicine for under-represented populations.
Open AccessBridging the Genomic Equity Gap with Context-Enhanced Risk Stratification in American Indians: the Strong Heart Study
Polygenic scores (PGS) show promise for disease risk stratification but suffer from limited portability across populations. American Indians face a disproportionate burden of cardiovascular disease yet remain significantly underrepresented in genomic research, limiting equitable access to precision medicine. Here, we evaluate whether integrating specific lifestyle and clinical context variables with PGS enhances risk prediction for cardiometabolic traits in 424,622 European from UK Biobank (UKB) and 3,157 American Indian populations from the Strong Heart Study (SHS). By comparing genetics-only models to full models incorporating context variables and gene-context interactions across blood pressure traits, coronary heart disease (CHD), and stroke, we found that the integration of context variables significantly improved prediction accuracy in both cohorts. Notably, for American Indian participants, the new model incorporating context and genetic interactions significantly improved model discrimination for CHD compared to an established clinical risk model. These findings suggest that modeling the interplay between inherited risk and modifiable factors can recover predictive power loss due to imperfect PGS transferability, offering a viable pathway toward more equitable and effective precision medicine for under-represented populations.
- Open Access
- 3 February 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (3) , e044310
Metabolomic Markers of Left Ventricular Structure, Diastolic Function, and Risk of Coronary Heart Disease: A Longitudinal Study in American Indian Individuals
Background: Subclinical alterations in left ventricular (LV) structure, diastolic function, and metabolic disturbances are associated with coronary heart disease (CHD) risk, but their relationships remained unclear. Large‐scale longitudinal metabolomic profiling of LV measures is lacking. Methods: Using untargeted metabolomics, we quantified 563 fasting plasma metabolites from 1799 American Indian individuals attending 2 exams (~5.5 years apart). We examined associations between metabolites and measures of LV structure (LV mass index, relative wall thickness), and diastolic function (peak early filling velocity to peak late filling velocity, isovolumic relaxation time, and deceleration time) using generalized estimating equation model. Findings were then replicated in an independent biracial cohort. Frailty Cox proportional hazards models were used to examine whether LV‐related metabolites are associated with the risk of CHD over a 20‐year follow‐up. Pathway enrichment analysis was performed to identify relevant metabolic pathways. Results: We identified 173 metabolites (47 named; q <0.05) associated with LV structure or diastolic function in the SHFS (Strong Heart Family Study), and some metabolites were confirmed in the biracial cohort. Three metabolites were additionally associated with incident CHD. Aspartic acid and palmitoleic acid were associated with lower LV mass index and peak early filling velocity to peak late filling velocity ratio and lower CHD risk (hazard ratios [HRs], 0.75 [95% CI, 0.56–0.99] to 0.81 [95% CI, 0.67–0.99]), whereas isothreonic acid was associated with higher relative wall thickness and higher CHD risk (HR, 1.15 [95% CI, 1.01–1.32]). LV‐related metabolites were enriched in arginine biosynthesis, alanine–aspartate–glutamate metabolism, and starch and sucrose metabolism. Conclusions: We identified metabolomic markers of LV structure and diastolic function, several of which that were independently associated with CHD risk, providing insight into metabolic pathways underlying LV subclinical changes and CHD.
- 3 February 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (3) , e044310
Open AccessMetabolomic Markers of Left Ventricular Structure, Diastolic Function, and Risk of Coronary Heart Disease: A Longitudinal Study in American Indian Individuals
Background: Subclinical alterations in left ventricular (LV) structure, diastolic function, and metabolic disturbances are associated with coronary heart disease (CHD) risk, but their relationships remained unclear. Large‐scale longitudinal metabolomic profiling of LV measures is lacking. Methods: Using untargeted metabolomics, we quantified 563 fasting plasma metabolites from 1799 American Indian individuals attending 2 exams (~5.5 years apart). We examined associations between metabolites and measures of LV structure (LV mass index, relative wall thickness), and diastolic function (peak early filling velocity to peak late filling velocity, isovolumic relaxation time, and deceleration time) using generalized estimating equation model. Findings were then replicated in an independent biracial cohort. Frailty Cox proportional hazards models were used to examine whether LV‐related metabolites are associated with the risk of CHD over a 20‐year follow‐up. Pathway enrichment analysis was performed to identify relevant metabolic pathways. Results: We identified 173 metabolites (47 named; q <0.05) associated with LV structure or diastolic function in the SHFS (Strong Heart Family Study), and some metabolites were confirmed in the biracial cohort. Three metabolites were additionally associated with incident CHD. Aspartic acid and palmitoleic acid were associated with lower LV mass index and peak early filling velocity to peak late filling velocity ratio and lower CHD risk (hazard ratios [HRs], 0.75 [95% CI, 0.56–0.99] to 0.81 [95% CI, 0.67–0.99]), whereas isothreonic acid was associated with higher relative wall thickness and higher CHD risk (HR, 1.15 [95% CI, 1.01–1.32]). LV‐related metabolites were enriched in arginine biosynthesis, alanine–aspartate–glutamate metabolism, and starch and sucrose metabolism. Conclusions: We identified metabolomic markers of LV structure and diastolic function, several of which that were independently associated with CHD risk, providing insight into metabolic pathways underlying LV subclinical changes and CHD.
- Open Access
- 11 December 2025
- Published by Elsevier in Atmospheric Pollution Research
- Vol. 17 (1)
Air pollution levels in American Indian communities in the Great Plains and Southwest: The Strong Heart Study
- 11 December 2025
- Published by Elsevier in Atmospheric Pollution Research
- Vol. 17 (1)
Open AccessAir pollution levels in American Indian communities in the Great Plains and Southwest: The Strong Heart Study
- Open Access
- 1 July 2025
- Published by SAGE Publications in Journal of Primary Care & Community Health
- Vol. 16
Evaluation of Honoring the Gift of Heart Health: The Strong Heart Study
Due to the higher rates of cardiovascular disease (CVD), the “Honoring the Gift of Heart Health” CVD risk factor educational program was developed specifically for American Indian communities. However, the effectiveness of educational program materials may change overtime and updates may be required to influence community health behaviors. Therefore, the aim of this project was to work with American Indians to provide recommendations on updating the “Honoring the Gift of Heart Health” CVD risk factor curriculum. To achieve this aim, we used a qualitative research design and a narrative inquiry approach. We used snowball sampling to recruit American Indian community stakeholders from the Oklahoma communities that participate in the Strong Heart Study, a study of CVD among American Indians. Throughout 2022, we conducted 3 focus group discussions, with 12 total participants. Two researchers transcribed the focus group audio recordings and conducted a content analysis to identify themes and patterns. American Indian participants provided recommendations regarding educational material format, topics, and incorporating culture into learning. On average, participants spent the highest percentage of time discussing themes related to nutrition (46%), followed by educational material format, risk factors, special groups, and new recommendations. In conclusion, this project was the first step in working with American Indian communities to update an educational intervention to address the persistent public health issue of CVD.
- 1 July 2025
- Published by SAGE Publications in Journal of Primary Care & Community Health
- Vol. 16
Open AccessEvaluation of Honoring the Gift of Heart Health: The Strong Heart Study
Due to the higher rates of cardiovascular disease (CVD), the “Honoring the Gift of Heart Health” CVD risk factor educational program was developed specifically for American Indian communities. However, the effectiveness of educational program materials may change overtime and updates may be required to influence community health behaviors. Therefore, the aim of this project was to work with American Indians to provide recommendations on updating the “Honoring the Gift of Heart Health” CVD risk factor curriculum. To achieve this aim, we used a qualitative research design and a narrative inquiry approach. We used snowball sampling to recruit American Indian community stakeholders from the Oklahoma communities that participate in the Strong Heart Study, a study of CVD among American Indians. Throughout 2022, we conducted 3 focus group discussions, with 12 total participants. Two researchers transcribed the focus group audio recordings and conducted a content analysis to identify themes and patterns. American Indian participants provided recommendations regarding educational material format, topics, and incorporating culture into learning. On average, participants spent the highest percentage of time discussing themes related to nutrition (46%), followed by educational material format, risk factors, special groups, and new recommendations. In conclusion, this project was the first step in working with American Indian communities to update an educational intervention to address the persistent public health issue of CVD.
- 1 July 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 246, 108226
Extracellular vesicle-encapsulated microRNA signatures of cigarette smoking and smoking-related harm
- 1 July 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 246, 108226
Extracellular vesicle-encapsulated microRNA signatures of cigarette smoking and smoking-related harm
- Open Access
- 27 March 2025
- Published by Centers for Disease Control and Prevention (CDC) in Preventing Chronic Disease
- Vol. 22, E12
Two Modeling Strategies in Analyzing Clustered Time-to-Event Data: the Strong Heart Family Study
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention.
- 27 March 2025
- Published by Centers for Disease Control and Prevention (CDC) in Preventing Chronic Disease
- Vol. 22, E12
Open AccessTwo Modeling Strategies in Analyzing Clustered Time-to-Event Data: the Strong Heart Family Study
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention.
- Open Access
- 29 October 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (21) , 6477
Implementation of Primary Immune Thrombocytopenia Clinical Practice Guidelines for Management of Pregnancy
Background: Managing primary immune thrombocytopenia (ITP) in pregnancy is challenging. Providers must balance bleeding risk against medication toxicity. The evaluation of the implementation of pregnancy-specific ITP clinical guidelines has not been widely studied. The goal of this study was to describe the implementation of pregnancy-specific ITP guidelines at an academic health center. Methods: We conducted a retrospective chart review at the University of Oklahoma Health system from 2011 to 2020. Descriptive statistics were calculated to summarize the characteristics of the study population. Management, according to the clinical guidelines (American Society of Hematology; American College of Obstetricians and Gynecologists) was evaluated during pregnancy and during/for delivery. Results: A total of 85 pregnant persons with ITP were included. The majority (68%; 58/85) delivered vaginally. There were 0 maternal deaths and 2 infant deaths. No patients had major bleeding during pregnancy. Postpartum hemorrhage was experienced by 14%. The management of thrombocytopenia during pregnancy was 100% adherent to the strong recommendation for severe (n = 13) and mild (n = 11) thrombocytopenia. However, 18/50 (36%) asymptomatic persons with moderate thrombocytopenia received treatment despite the strong recommendation that treatment was unnecessary. Additionally, 8/21 (38%) persons with moderate thrombocytopenia received treatment to increase platelet counts for epidural anesthesia despite the guideline’s suggestion that it was unnecessary. Conclusions: During pregnancy, patients with severe thrombocytopenia (i.e., most at risk of bleeding) received treatment. On the other hand, approximately 40% of pregnant persons with ITP received unnecessary treatment for moderate asymptomatic thrombocytopenia either during pregnancy or for an epidural. Utilizing clinical practice guidelines would reduce the overtreatment of pregnant persons which would reduce the potential side effects of therapy for the mother and infant.
- 29 October 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (21) , 6477
Open AccessImplementation of Primary Immune Thrombocytopenia Clinical Practice Guidelines for Management of Pregnancy
Background: Managing primary immune thrombocytopenia (ITP) in pregnancy is challenging. Providers must balance bleeding risk against medication toxicity. The evaluation of the implementation of pregnancy-specific ITP clinical guidelines has not been widely studied. The goal of this study was to describe the implementation of pregnancy-specific ITP guidelines at an academic health center. Methods: We conducted a retrospective chart review at the University of Oklahoma Health system from 2011 to 2020. Descriptive statistics were calculated to summarize the characteristics of the study population. Management, according to the clinical guidelines (American Society of Hematology; American College of Obstetricians and Gynecologists) was evaluated during pregnancy and during/for delivery. Results: A total of 85 pregnant persons with ITP were included. The majority (68%; 58/85) delivered vaginally. There were 0 maternal deaths and 2 infant deaths. No patients had major bleeding during pregnancy. Postpartum hemorrhage was experienced by 14%. The management of thrombocytopenia during pregnancy was 100% adherent to the strong recommendation for severe (n = 13) and mild (n = 11) thrombocytopenia. However, 18/50 (36%) asymptomatic persons with moderate thrombocytopenia received treatment despite the strong recommendation that treatment was unnecessary. Additionally, 8/21 (38%) persons with moderate thrombocytopenia received treatment to increase platelet counts for epidural anesthesia despite the guideline’s suggestion that it was unnecessary. Conclusions: During pregnancy, patients with severe thrombocytopenia (i.e., most at risk of bleeding) received treatment. On the other hand, approximately 40% of pregnant persons with ITP received unnecessary treatment for moderate asymptomatic thrombocytopenia either during pregnancy or for an epidural. Utilizing clinical practice guidelines would reduce the overtreatment of pregnant persons which would reduce the potential side effects of therapy for the mother and infant.